An economic analysis of COAPT data suggests edge-to-edge TMVR with the MitraClip device is a more affordable long-term treatment option than guideline-directed medical therapy alone for patients with severe secondary MR—but the steep cost of an index TMVR procedure might eclipse that benefit.

Cardiologist John Stobeck, accused of inappropriately touching a female patient during a medical exam in 2012, headed to trial on Tuesday, the North Jersey Record reports.

North Carolina Children’s Hospital has received the go-ahead from an external advisory board to resume complex heart surgeries after a New York Times investigation ground the program to a halt three months ago, the Times reports.

With minimally invasive structural procedures crowding out their surgical counterparts, how are physicians and hospitals preparing for the new reality? 

French medtech startup Robocath has raised 5 million euros—the equivalent of $5.5 million in U.S. currency—in support of its cardiovascular robotics system, the company announced this month.

Researchers have uncovered evidence of a global “epidemiological transition” that’s seeing cancer overtake cardiovascular disease as the biggest killer in developed countries, Reuters reports.

The U.S. FDA this month granted Fast Track designation to AstraZeneca for the development of Farxiga, or dapagliflozin. 

Cardiology compensation jumped 4.4% while productivity remained relatively stagnant between 2017 and 2018, AMGA reported in its 32nd annual Medical Group Compensation and Productivity Survey.